HomeSANN • SWX
add
Santhera Pharmaceuticals Holding AG
Previous close
CHF 8.37
Day range
CHF 8.29 - CHF 8.43
Year range
CHF 7.14 - CHF 14.62
Market cap
105.92M CHF
Avg Volume
21.33K
P/E ratio
1.67
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (CHF) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 49.74M | 8,033.69% |
Operating expense | 13.35M | 22.28% |
Net income | 39.06M | 288.91% |
Net profit margin | 78.53 | 102.32% |
Earnings per share | — | — |
EBITDA | 36.12M | 445.01% |
Effective tax rate | 0.16% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.37M | 2,144.64% |
Total assets | 109.63M | 72.03% |
Total liabilities | 49.69M | -53.74% |
Total equity | 59.94M | — |
Shares outstanding | 11.32M | — |
Price to book | 1.58 | — |
Return on assets | 81.49% | — |
Return on capital | 109.62% | — |
Cash Flow
Net change in cash
| (CHF) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 39.06M | 288.91% |
Cash from operations | 31.31M | 450.16% |
Cash from investing | -11.86M | -503.41% |
Cash from financing | -5.08M | -196.62% |
Net change in cash | 14.35M | 352.96% |
Free cash flow | 8.96M | 192.22% |
About
Founded
2004
Website
Employees
45
